Financing, Equity Capital Markets

TELA Bio, Inc.

06/20
|
$48.0 Million
Piper Sandler served as bookrunner for TELA Bio, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Med-Tech